These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15566412)

  • 21. High levels of luteinizing hormone analog stimulate gonadal and adrenal tumorigenesis in mice transgenic for the mouse inhibin-alpha-subunit promoter/Simian virus 40 T-antigen fusion gene.
    Mikola M; Kero J; Nilson JH; Keri RA; Poutanen M; Huhtaniemi I
    Oncogene; 2003 May; 22(21):3269-78. PubMed ID: 12761497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thymic epithelial neoplasms in transgenic mice expressing SV40 T antigen under the control of an erythroid-specific enhancer.
    Teitz T; Chang JC; Kan YW; Yen TS
    J Pathol; 1995 Nov; 177(3):309-15. PubMed ID: 8551394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progression of prostate cancer from a subset of p63-positive basal epithelial cells in FG/Tag transgenic mice.
    Reiner T; de Las Pozas A; Parrondo R; Perez-Stable C
    Mol Cancer Res; 2007 Nov; 5(11):1171-9. PubMed ID: 17982114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inducible formation of liver tumors in transgenic mice.
    Rüther U; Woodroofe C; Fattori E; Ciliberto G
    Oncogene; 1993 Jan; 8(1):87-93. PubMed ID: 8423999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of experimental autoimmune encephalomyelitis in transgenic mice expressing ovalbumin in oligodendrocytes.
    Cao Y; Toben C; Na SY; Stark K; Nitschke L; Peterson A; Gold R; Schimpl A; Hünig T
    Eur J Immunol; 2006 Jan; 36(1):207-15. PubMed ID: 16342234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A transgenic mouse model for lung adenocarcinoma.
    Sandmöller A; Halter R; Suske G; Paul D; Beato M
    Cell Growth Differ; 1995 Jan; 6(1):97-103. PubMed ID: 7718490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estradiol-dependent uterine leiomyomas in transgenic mice.
    Romagnolo B; Molina T; Leroy G; Blin C; Porteux A; Thomasset M; Vandewalle A; Kahn A; Perret C
    J Clin Invest; 1996 Aug; 98(3):777-84. PubMed ID: 8698870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progressive and regressive fate of lens tumors correlates with subtle differences in transgene expression in gamma F-crystallin-SV40 T antigen transgenic mice.
    Bryce DM; Liu Q; Khoo W; Tsui LC; Breitman ML
    Oncogene; 1993 Jun; 8(6):1611-20. PubMed ID: 8389033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transgenic mice with pigmented intraocular tumors: tissue of origin and treatment.
    Syed NA; Windle JJ; Darjatmoko SR; Lokken JM; Steeves RA; Chappell R; Wallow IH; Koop BA; Mangold G; Howes KA; Albert DM
    Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2800-5. PubMed ID: 9856795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple neuroendocrine tumours in transgenic mice induced by c-kit-SV40 T antigen fusion genes.
    Bossé P; Bernex F; De Sepulveda P; Salaün P; Panthier JJ
    Oncogene; 1997 Jun; 14(22):2661-70. PubMed ID: 9178764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SV40 rodent tumour models as paradigms of human disease: transgenic mouse models.
    Furth PA
    Dev Biol Stand; 1998; 94():281-7. PubMed ID: 9776248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sympathetic hyperplasia and neuroblastomas in transgenic mice expressing polyoma middle T antigen.
    Aguzzi A; Wagner EF; Williams RL; Courtneidge SA
    New Biol; 1990 Jun; 2(6):533-43. PubMed ID: 2088503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurocristopathy resembling neurofibromatosis type 1 in an NGF-SV40 transgenic line.
    Mazarakis ND; Yannoutsos N; el-Jabbour JN; Hatton W; Fletcher R; Grosveld F
    Genes Cells; 1996 Jan; 1(1):125-37. PubMed ID: 9078372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developmental study of SV40 large T antigen expression in transgenic mice with choroid plexus neoplasia.
    Messing A; Pinkert CA; Palmiter RD; Brinster RL
    Oncogene Res; 1988; 3(1):87-97. PubMed ID: 3060799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma.
    Boissan M; Wendum D; Arnaud-Dabernat S; Munier A; Debray M; Lascu I; Daniel JY; Lacombe ML
    J Natl Cancer Inst; 2005 Jun; 97(11):836-45. PubMed ID: 15928304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncolytic herpes simplex virus vector therapy of breast cancer in C3(1)/SV40 T-antigen transgenic mice.
    Liu R; Varghese S; Rabkin SD
    Cancer Res; 2005 Feb; 65(4):1532-40. PubMed ID: 15735042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic mechanisms affect mutant p53 transgene expression in WAP-mutp53 transgenic mice.
    Krepulat F; Löhler J; Heinlein C; Hermannstädter A; Tolstonog GV; Deppert W
    Oncogene; 2005 Jul; 24(29):4645-59. PubMed ID: 15870706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simian virus 40 tumor antigen expression and immunophenotypic profile of AIDS-related non-Hodgkin's lymphoma.
    Vilchez RA; Lopez-Terrada D; Middleton JR; Finch CJ; Killen DE; Zanwar P; Jorgensen JL; Butel JS
    Virology; 2005 Nov; 342(1):38-46. PubMed ID: 16122775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of a novel neuroblastoma mouse model.
    Iwakura H; Ariyasu H; Kanamoto N; Hosoda K; Nakao K; Kangawa K; Akamizu T
    Int J Oncol; 2008 Dec; 33(6):1195-9. PubMed ID: 19020752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of cell cycle regulators in phenotypic variants of transgenically induced bladder tumors: implications for tumor behavior.
    Garcia-España A; Salazar E; Sun TT; Wu XR; Pellicer A
    Cancer Res; 2005 Feb; 65(4):1150-7. PubMed ID: 15734997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.